neutral
4 days agoCorona Remedies IPO allotment live; strong grey market premium hints listing gains
Corona Remedies’ ₹655.37 crore IPO, priced at ₹1,008–₹1,062 per share, is set for basis of allotment on 11 December 2025 after closing on 10 December. Investors can check status via NSE/BSE and registrar Bigshare Services. Grey market premium stood near ₹295, implying a potential listing price of about ₹1,357 or ~28% above the band. Shares will debut on the BSE and NSE around 15 December 2025.
Companies:
- Corona Remedies Ltd.
Tags:
- ipo
- india
Explore:Mutual Fund Home
neutral
4 days agoCorona Remedies IPO allotment live; strong grey market premium hints listing gains
Corona Remedies’ ₹655.37 crore IPO, priced at ₹1,008–₹1,062 per share, is set for basis of allotment on 11 December 2025 after closing on 10 December. Investors can check status via NSE/BSE and registrar Bigshare Services. Grey market premium stood near ₹295, implying a potential listing price of about ₹1,357 or ~28% above the band. Shares will debut on the BSE and NSE around 15 December 2025.
Companies:
- Corona Remedies Ltd.
Tags:
- ipo
- india
Explore:Mutual Fund Home
1 min read
67 words
Corona Remedies IPO allotment is due on 11 December; strong GMP suggests up to ~28% listing gains ahead of its 15 December debut.
Corona Remedies’ ₹655.37 crore IPO, priced at ₹1,008–₹1,062 per share, is set for basis of allotment on 11 December 2025 after closing on 10 December. Investors can check status via NSE/BSE and registrar Bigshare Services. Grey market premium stood near ₹295, implying a potential listing price of about ₹1,357 or ~28% above the band. Shares will debut on the BSE and NSE around 15 December 2025.
Corona Remedies’ ₹655.37 crore IPO, priced at ₹1,008–₹1,062 per share, is set for basis of allotment on 11 December 2025 after closing on 10 December. Investors can check status via NSE/BSE and registrar Bigshare Services. Grey market premium stood near ₹295, implying a potential listing price of about ₹1,357 or ~28% above the band. Shares will debut on the BSE and NSE around 15 December 2025.
Companies:
- Corona Remedies Ltd.
Tags:
- ipo
- india
- ipo
- india
- pharma
- markets
Dec 11, 2025 • 17:20